Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015, Article ID 582163, 5 pages
http://dx.doi.org/10.1155/2015/582163
Clinical Study

The Effect of Intravenous Iron Treatment on Quality of Life in Inflammatory Bowel Disease Patients with Nonanemic Iron Deficiency

Department of Gastroenterology, İzmir Atatürk Training and Research Hospital, Izmir Kâtip Çelebi University, Karabaglar, 35160 İzmir, Turkey

Received 16 September 2014; Revised 22 December 2014; Accepted 5 January 2015

Academic Editor: Giorgos Bamias

Copyright © 2015 Cem Çekiç et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Gasche, M. C. E. Lomer, I. Cavill, and G. Weiss, “Iron, anaemia, and inflammatory bowel diseases,” Gut, vol. 53, no. 8, pp. 1190–1197, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Agarwal, “Nonhematological benefits of iron,” The American Journal of Nephrology, vol. 27, no. 6, pp. 565–571, 2007. View at Publisher · View at Google Scholar
  3. L. T. Pizzi, C. M. Weston, N. I. Goldfarb et al., “Impact of chronic conditions on quality of life in patients with inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 12, no. 1, pp. 47–52, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. T. W. Lee, M. R. Kolber, R. N. Fedorak, and S. V. van Zanten, “Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis,” Journal of Crohn's and Colitis, vol. 6, no. 3, pp. 267–275, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Befrits, O. Wikman, L. Blomquist et al., “Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life,” Scandinavian Journal of Gastroenterology, vol. 48, no. 9, pp. 1027–1032, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Reinisch, Y. Chowers, S. Danese et al., “The management of iron deficiency in inflammatory bowel disease—an online tool developed by the RAND/UCLA appropriateness method,” Alimentary Pharmacology and Therapeutics, vol. 38, no. 9, pp. 1109–1118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Comin-Colet, M. Lainscak, K. Dickstein et al., “The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study,” European Heart Journal, vol. 34, no. 1, pp. 30–38, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Vadasz, V. Ries, and W. H. Oertel, “Intravenous iron sucrose for restless legs syndrome in pregnant women with low serum ferritin,” Sleep Medicine, vol. 14, no. 11, pp. 1214–1216, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. W. R. Best, J. M. Becktel, J. W. Singleton, and F. Kern Jr., “Development of a Crohn's disease activity index. National cooperative Crohn's disease study,” Gastroenterology, vol. 70, no. 3, pp. 439–444, 1976. View at Google Scholar · View at Scopus
  10. S. Lichtiger, D. H. Present, A. Kornbluth et al., “Cyclosporine in severe ulcerative colitis refractory to steroid therapy,” The New England Journal of Medicine, vol. 330, no. 26, pp. 1841–1845, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. G. van Assche, A. Dignass, B. Bokemeyer et al., “Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: special situations,” Journal of Crohn's and Colitis, vol. 7, no. 1, pp. 1–33, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. M. S. Silverberg, J. Satsangi, T. Ahmad et al., “Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology,” Canadian Journal of Gastroenterology, vol. 19, supplement A, pp. 5A–36A, 2005. View at Google Scholar · View at Scopus
  13. G. Bodemar, S. Kechagias, S. Almer, and B. G. Danielson, “Treatment of anaemia in inflammatory bowel disease with iron sucrose,” Scandinavian Journal of Gastroenterology, vol. 39, no. 5, pp. 454–458, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. E. McDermott, D. Keegan, K. Byrne, G. A. Doherty, and H. E. Mulcahy, “The Short Health Scale: a valid and reliable measure of health related quality of life in English speaking inflammatory bowel disease patients,” Journal of Crohn's and Colitis, vol. 7, no. 8, pp. 616–621, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. J. E. Ware, M. Kosinski, and J. E. Dewey, How to Score Version 2 of the SF-36 Health Survey, QualityMetric, Lincoln, RI, USA, 3rd edition, 2001.
  16. P.-A. Krayenbuehl, E. Battegay, C. Breymann, J. Furrer, and G. Schulthess, “Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration,” Blood, vol. 118, no. 12, pp. 3222–3227, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Comín-Colet, C. Enjuanes, G. González et al., “Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status,” European Journal of Heart Failure, vol. 15, no. 10, pp. 1164–1172, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Beigel, B. Löhr, R. P. Laubender et al., “Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease,” Digestion, vol. 85, no. 1, pp. 47–54, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J. P. Gisbert and F. Gomollón, “Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease,” The American Journal of Gastroenterology, vol. 103, no. 5, pp. 1299–1307, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. C. W. Wells, S. Lewis, J. R. Barton, and S. Corbett, “Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients,” Inflammatory Bowel Diseases, vol. 12, no. 2, pp. 123–130, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Evstatiev, P. Marteau, T. Iqbal et al., “FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease,” Gastroenterology, vol. 141, no. 3, pp. 846.e2–853.e2, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Gasche, A. Berstad, R. Befrits et al., “Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases,” Inflammatory Bowel Diseases, vol. 13, no. 12, pp. 1545–1553, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. G. van Assche, A. Dignass, W. Reinisch et al., “The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: special situations,” Journal of Crohn's and Colitis, vol. 4, no. 1, pp. 63–101, 2010. View at Publisher · View at Google Scholar
  24. R. Evstatiev, O. Alexeeva, B. Bokemeyer et al., “Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease,” Clinical Gastroenterology and Hepatology, vol. 11, no. 3, pp. 269–277, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Muñoz, S. Gómez-Ramírez, and J. A. García-Erce, “Intravenous iron in inflammatory bowel disease,” World Journal of Gastroenterology, vol. 15, no. 37, pp. 4666–4674, 2009. View at Publisher · View at Google Scholar · View at Scopus